Award
Delivery Order #SPE2DR26FL220
Delivery Order for Actemra Syringes to AmerisourceBergen Drug Corp
Buyer
Defense Logistics Agency
Award Amount
$4,898.47
Ceiling
$4,898.47
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26FL220
NAICS
424210
This award represents a delivery order under a long-term indefinite delivery/indefinite quantity (IDIQ) contract previously granted to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company. The contract involves the procurement of Actemra 162 mg/0.9 ml syringes, a vital pharmaceutical product used within healthcare settings. The significance of this delivery order lies in its support of sustained access to critical medications, contributing to reliable healthcare supply chains. The scope covers the delivery of specified pharmaceutical syringes with precise dosage and packaging. This delivery order was likely issued as part of a competitive contracting process under the parent IDIQ agreement, which manages pharmaceutical product distribution. The order is scheduled for a brief, specific timeframe, reflecting a timely fulfillment aligned with healthcare demands. The parent contract facilitates a long-term partnership aimed at enhancing medication availability for healthcare agencies.
Description
4570821522!ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML